HALLETT DAVID (Chief Scientific Officer) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/18/2026ACC: 0002006495-26-000012
Officer· Chief Scientific Officer
Since Feb 2026
-26.66K
Net shares
Net seller
$84.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
26.66K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−26.66K
Price / share
$3.16
Trade value
$84.24K
% of position
2.5%
8/17/2026
1.07M→1.04M
Total
Net shares
−26.66K
Net value
-$84.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/17/2026 | F · Tax Withholding | −26.66K | $3.16 | $84.24K | 2.5% | 1.07M | 1.04M |
| Total | −26.66K | -$84.24K | ||||||
Derivative Transactions0
No derivative transactions reported